Columbia Herbert Irving Cancer Center – Leukemia Program is a cancer treatment center located in New York, New York. This specialized program focuses on the diagnosis, treatment, and management of leukemia, providing patients with access to a multidisciplinary team of healthcare professionals. Situated at 161 Fort Washington Avenue, the center integrates clinical care with ongoing research to offer advanced therapeutic options tailored to individual patient needs.
The Leukemia Program operates within a comprehensive cancer center environment, which supports a collaborative approach among oncologists, hematologists, and research scientists. This enables the development and application of innovative treatment protocols, including chemotherapy, targeted therapies, and bone marrow transplantation. Patients benefit from personalized care plans that address both the physical and emotional aspects of leukemia, ensuring thorough support throughout the treatment journey.
In addition to direct patient care, the center is engaged in clinical trials and cutting-edge research aimed at improving leukemia outcomes. This research-driven environment helps facilitate access to new treatments and emerging technologies, often not available elsewhere. The combination of clinical expertise and scientific inquiry positions Columbia Herbert Irving Cancer Center – Leukemia Program as a vital resource for individuals seeking specialized leukemia care in New York City.
With a focus on integrating state-of-the-art medical advancements and compassionate care, the center strives to address the complexities of leukemia treatment. Patients have access to a range of supportive services designed to enhance quality of life and manage symptoms associated with the disease and its treatment. The center’s location in New York City makes it accessible to a diverse patient population seeking expert care for hematologic malignancies.
